Anaeropharma Co-Opts Microbe For Targeted Fight Against Hypoxic Tumors
Executive Summary
Japanese venture Anaeropharma Science is working on a unique approach to targeted drug delivery it says confers advantages including fewer systemic side effects, and the technology is already seeing validation through several research deals with major Japanese pharma companies.